TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide

作者: Janine Bilsborough , Catherine Uyttenhove , Didier Colau , Philippe Bousso , Claude Libert

DOI: 10.4049/JIMMUNOL.169.6.3053

关键词: Ex vivoTumor Specific PeptideTumor necrosis factor alphaImmunotherapyToxicityCD8Molecular biologyCytotoxic T cellBiologyMSRAImmunology

摘要: We immunized mice with antigenic peptide P815E, which is presented by H-2K(d) and recognized tumor-specific CTL raised against P815 tumor cells. This encoded the ubiquitously expressed gene MsrA carries a mutated residue conferring specificity. Unexpectedly, we observed severe toxicity occurring in early hours after third injection, resulting death of most within 24 h. The toxic syndrome was reminiscent TNF-induced shock, sera ill contained high levels TNF. Toxicity prevented injection neutralizing anti-TNF Abs, confirming involvement Depletion CD8(+) T cells could also prevent toxicity, ex vivo experiments confirmed that lymphocytes were major cellular source TNF mice. Tetramer analysis indicated massive expansion P815E-specific cells, up to >60% circulating CD8+ lymphocytes. A similar specific following immunization another peptide, P1A injected form covalently linked an immunostimulatory derived from IL-1. conclude caused lymphocytes, are extensively amplified QS21-based adjuvant produce upon further stimulation peptide. Our results suggest immunotherapy trials involving new peptides should be pursued caution include careful monitoring cell response.

参考文章(38)
L. Chatenoud, C. Ferran, J.-F. Bach, The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. Current Topics in Microbiology and Immunology. ,vol. 174, pp. 121- 134 ,(1991) , 10.1007/978-3-642-50998-8_9
Marriott Jb, Guckian M, Dalgleish Ag, Cookson S, Stirling D, Goodbourn S, Westby M, Shire Mg, Muller G, CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. Journal of Immunology. ,vol. 161, pp. 4236- 4243 ,(1998)
Philippe Bousso, Fabrice Lemaı̂tre, Janine Bilsborough, Philippe Kourilsky, Facing Two T Cell Epitopes: A Degree of Randomness in the Primary Response Is Lost Upon Secondary Immunization The Journal of Immunology. ,vol. 165, pp. 760- 767 ,(2000) , 10.4049/JIMMUNOL.165.2.760
P C Familletti, A G Wolitzky, D S Schoenhaut, U Gubler, M K Gately, P M Quinn, C M Dwyer, W McComas, A O Chua, Cloning and expression of murine IL-12. Journal of Immunology. ,vol. 148, pp. 3433- 3440 ,(1992)
P A Kiener, G Rodgers, P F Lin, G Warr, J Desiderio, F Marek, Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. Journal of Immunology. ,vol. 141, pp. 870- 874 ,(1988)
Thomas F Gajewski, Jean-Christophe Renauld, Aline Van Pel, T Boon, None, Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. Journal of Immunology. ,vol. 154, pp. 5637- 5648 ,(1995)
S Silla, F Fallarino, Thierry Boon, Catherine Uyttenhove, None, Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL. European Cytokine Network. ,vol. 10, pp. 181- 189 ,(1999)
Janine Bilsborough, Aline Van Pel, Catherine Uyttenhove, Thierry Boon, Benoı̂t J Van den Eynde, None, Identification of a Second Major Tumor-Specific Antigen Recognized by CTLs on Mouse Mastocytoma P815 Journal of Immunology. ,vol. 162, pp. 3534- 3540 ,(1999)
Nicholas P. Restifo, Steven A. Rosenberg, Kari R. Irvine, Barbra Jill McCabe, Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL. Journal of Immunology. ,vol. 154, pp. 4651- 4657 ,(1995)